Life Insurance Corporation of India delivered exceptional first-quarter results with standalone net profit surging 23% year-on-year to ₹13,492 crore in Q1 FY27, compared with ₹10,986 crore in the same period last year. The company also reported premium income growth during the quarter, demonstrating strong operational performance. This robust financial performance comes alongside the successful completion of LIC's ₹31,552 crore offer for sale, which received overwhelming institutional investor interest with bids amounting to ₹36,400 crore received on Tuesday. MD R Doraiswamy attributes this strong response to growing confidence in the insurance behemoth, with the OFS helping achieve the 10% public shareholding target ahead of schedule.
Following the OFS completion, LIC will focus on growth, margins, and distribution expansion while evaluating opportunities in health insurance and fintech sectors. As reported by The Economic Times, the insurer has embarked on a significant technology transformation and is open to investing in fintech or insurtech companies that require growth capital and provide good investment opportunities. The company is also considering health insurance opportunities but emphasizes ensuring claims settlement ratios don't impact LIC's brand reputation. Doraiswamy noted that the company has strictly followed the practice of keeping distribution costs within accepted levels, with commissions spread over multiple years to maintain agent relationships. The agency channel will continue to be LIC's strength, with business through banks and alternative channels having increased from less than 3% in 2022 to over 8%, including digital channels, which can increase to over 10%.
LIC's bancassurance channel has grown to over 8% of new business, up from less than 3% in 2022, with plans to increase to over 10% including digital channels. According to reports from The Economic Times, this growth is not at the cost of the agency channel, which remains LIC's strength. The company continues building relationships with other banks, brokers, corporate agents, and web aggregators while maintaining IDBI Bank as a premier bancassurance partner. Fairfax Holdings has been finalized for the IDBI Bank stake sale, with the significant deal expected to be worth approximately ₹53,000 crore. Fairfax's offer of ₹81 per share is higher than last year's bid, marking the largest foreign investment in an Indian bank. Doraiswamy emphasized that IDBI has been a very premier partner in terms of bancassurance, with those strengths continuing irrespective of the bank's ownership structure.
LIC's stock has remained below IPO price, with Doraiswamy citing very low public float as a contributing factor. As reported by The Economic Times, the company has addressed this through 1:1 bonus shares issuance and increased dividend yields. The government maintains plans to increase public float to 25% by 2032, with LIC having until 2032 to meet minimum public shareholding norms. The government will likely not sell more LIC shares for 18-24 months, which could lead to better price discovery by reducing supply overhang. Looking ahead, LIC maintains its objective of providing insurance coverage for every insurable person while continuing market leadership. The company expects to benefit from current market conditions that keep yields high, creating opportunities in both equity and debt investments, with Doraiswamy noting that the regulator's consideration of trail-based commissions and distribution cost reforms will have minimal impact on LIC's practices.
The company is also exploring health insurance opportunities but emphasizes ensuring claims settlement ratios don't impact LIC's brand reputation, with Doraiswamy stating that insurance is not a pull product and agents play the role of first-line underwriters who need to understand risks properly. LIC recently saw a 6.5% stake sale well received by markets, demonstrating continued investor confidence. The company's ₹60 lakh crore in assets under management provides opportunities across both equity and debt markets, with the company maintaining a contrarian investment approach, buying in market dips and realizing profits during upturns. ULIPs have taken a beating during volatile periods, but the company is making efforts to recover in this segment, while annuity performance has been affected by remittance issues and liquidity challenges.
